Literature DB >> 21226535

A nuclear magnetic resonance-based structural rationale for contrasting stoichiometry and ligand binding site(s) in fatty acid-binding proteins.

Yan He1, Rima Estephan, Xiaomin Yang, Adriana Vela, Hsin Wang, Cédric Bernard, Ruth E Stark.   

Abstract

Liver fatty acid-binding protein (LFABP) is a 14 kDa cytosolic polypeptide, differing from other family members in the number of ligand binding sites, the diversity of bound ligands, and the transfer of fatty acid(s) to membranes primarily via aqueous diffusion rather than direct collisional interactions. Distinct two-dimensional (1)H-(15)N nuclear magnetic resonance (NMR) signals indicative of slowly exchanging LFABP assemblies formed during stepwise ligand titration were exploited, without determining the protein-ligand complex structures, to yield the stoichiometries for the bound ligands, their locations within the protein binding cavity, the sequence of ligand occupation, and the corresponding protein structural accommodations. Chemical shifts were monitored for wild-type LFABP and an R122L/S124A mutant in which electrostatic interactions viewed as being essential to fatty acid binding were removed. For wild-type LFABP, the results compared favorably with the data for previous tertiary structures of oleate-bound wild-type LFABP in crystals and in solution: there are two oleates, one U-shaped ligand that positions the long hydrophobic chain deep within the cavity and another extended structure with the hydrophobic chain facing the cavity and the carboxylate group lying close to the protein surface. The NMR titration validated a prior hypothesis that the first oleate to enter the cavity occupies the internal protein site. In contrast, (1)H and (15)N chemical shift changes supported only one liganded oleate for R122L/S124A LFABP, at an intermediate location within the protein cavity. A rationale based on protein sequence and electrostatics was developed to explain the stoichiometry and binding site trends for LFABPs and to put these findings into context within the larger protein family.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21226535      PMCID: PMC3072248          DOI: 10.1021/bi101307h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  43 in total

Review 1.  The fatty acid transport function of fatty acid-binding proteins.

Authors:  J Storch; A E Thumser
Journal:  Biochim Biophys Acta       Date:  2000-06-26

2.  NMR study of the differential contributions of residues of transforming growth factor alpha to association with its receptor.

Authors:  C McInnes; S Grothe; M O'Connor-McCourt; B D Sykes
Journal:  Protein Eng       Date:  2000-03

Review 3.  Liver fatty acid binding protein: species variation and the accommodation of different ligands.

Authors:  J Thompson; A Reese-Wagoner; L Banaszak
Journal:  Biochim Biophys Acta       Date:  1999-11-23

4.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

5.  The crystal structure of the liver fatty acid-binding protein. A complex with two bound oleates.

Authors:  J Thompson; N Winter; D Terwey; J Bratt; L Banaszak
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

6.  Fatty acid transfer from liver and intestinal fatty acid-binding proteins to membranes occurs by different mechanisms.

Authors:  K T Hsu; J Storch
Journal:  J Biol Chem       Date:  1996-06-07       Impact factor: 5.157

Review 7.  New insights into the structure and function of fatty acid-binding proteins.

Authors:  A W Zimmerman; J H Veerkamp
Journal:  Cell Mol Life Sci       Date:  2002-07       Impact factor: 9.261

Review 8.  The emerging functions and mechanisms of mammalian fatty acid-binding proteins.

Authors:  Judith Storch; Betina Corsico
Journal:  Annu Rev Nutr       Date:  2008       Impact factor: 11.848

9.  Effect on ligand binding of arginine mutations in recombinant rat liver fatty acid-binding protein.

Authors:  A E Thumser; C Evans; A F Worrall; D C Wilton
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

10.  Mutations of recombinant rat liver fatty acid-binding protein at residues 102 and 122 alter its structural integrity and affinity for physiological ligands.

Authors:  A E Thumser; J Voysey; D C Wilton
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

View more
  7 in total

1.  Fatty acid induced remodeling within the human liver fatty acid-binding protein.

Authors:  Ashwani Sharma; Amit Sharma
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

2.  Liver fatty acid-binding protein binds monoacylglycerol in vitro and in mouse liver cytosol.

Authors:  William S Lagakos; Xudong Guan; Shiu-Ying Ho; Luciana Rodriguez Sawicki; Betina Corsico; Sarala Kodukula; Kaeko Murota; Ruth E Stark; Judith Storch
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

3.  Solution structure and backbone dynamics of human liver fatty acid binding protein: fatty acid binding revisited.

Authors:  Jun Cai; Christian Lücke; Zhongjing Chen; Ye Qiao; Elena Klimtchuk; James A Hamilton
Journal:  Biophys J       Date:  2012-06-05       Impact factor: 4.033

4.  A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonists.

Authors:  Rahul Patil; Biswaranjan Mohanty; Bonan Liu; Indu R Chandrashekaran; Stephen J Headey; Martin L Williams; Craig S Clements; Olga Ilyichova; Bradley C Doak; Patrick Genissel; Richard J Weaver; Laurent Vuillard; Michelle L Halls; Christopher J H Porter; Martin J Scanlon
Journal:  J Biol Chem       Date:  2018-12-31       Impact factor: 5.157

5.  All-Purpose Containers? Lipid-Binding Protein - Drug Interactions.

Authors:  Tiziana Beringhelli; Elisabetta Gianazza; Daniela Maggioni; Sandra Scanu; Chiara Parravicini; Cristina Sensi; Hugo L Monaco; Ivano Eberini
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

6.  FABP1 controls hepatic transport and biotransformation of Δ9-THC.

Authors:  Matthew W Elmes; Lauren E Prentis; Luke L McGoldrick; Christopher J Giuliano; Joseph M Sweeney; Olivia M Joseph; Joyce Che; Gregory S Carbonetti; Keith Studholme; Dale G Deutsch; Robert C Rizzo; Steven E Glynn; Martin Kaczocha
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

7.  Quantitative Chemical Proteomics Reveals Interspecies Variations on Binding Schemes of L-FABP with Perfluorooctanesulfonate.

Authors:  Jiajun Han; Jesse Fu; Jianxian Sun; David Ross Hall; Diwen Yang; Donovan Blatz; Keith Houck; Carla Ng; Jon Doering; Carlie LaLone; Hui Peng
Journal:  Environ Sci Technol       Date:  2021-06-16       Impact factor: 11.357

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.